−16.55TWD
−2.14 BTWD
61.41 MTWD
102.43 M
About TANVEX BIOPHARMA INC
Sector
Headquarters
Taipei
Founded
2013
Website
ISIN
KYG8676P1037
FIGI
BBG009S5RJQ9
Tanvex BioPharma, Inc. operates as clinical stage company, which engages in the research and development, production, and sale of pharmaceutical products. It products include filgrastim, trastuzumab, pegfilgrastim, bevacizumab, and pertuzumab injections. The company was founded by Yu Tien Chao on May 8, 2013 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 6541 is featured.
Frequently Asked Questions
The current price of 6541 is 46.80 TWD — it has decreased by 0.85% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange TANVEX BIOPHARMA INC stocks are traded under the ticker 6541.
TANVEX BIOPHARMA INC is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
6541 stock is 2.27% volatile and has beta coefficient of −0.65. Check out the list of the most volatile stocks — is TANVEX BIOPHARMA INC there?
6541 earnings for the last quarter are −3.83 TWD whereas the estimation was −4.93 TWD which accounts for 22.22% surprise. Estimated earnings for the next quarter are −3.52 TWD. See more details about TANVEX BIOPHARMA INC earnings.
Yes, you can track TANVEX BIOPHARMA INC financials in yearly and quarterly reports right on TradingView.
6541 stock has fallen by 3.90% compared to the previous week, the month change is a 7.90% fall, over the last year TANVEX BIOPHARMA INC has showed a 41.67% decrease.
6541 net income for the last quarter is −518.02 M TWD, while the quarter before that showed −505.34 M TWD of net income which accounts for −2.51% change. Track more TANVEX BIOPHARMA INC financial stats to get the full picture.
Today TANVEX BIOPHARMA INC has the market capitalization of 7.55 B, it has increased by 0.10% over the last week.
No, 6541 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6541 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TANVEX BIOPHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TANVEX BIOPHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TANVEX BIOPHARMA INC stock shows the sell signal. See more of TANVEX BIOPHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TANVEX BIOPHARMA INC EBITDA is −1.78 B TWD, and current EBITDA margin is −2.89 K%. See more stats in TANVEX BIOPHARMA INC financial statements.